The evolving law of CRISPR interview with professor Jacob Sherkow of New York Law School

Kevin Davies, Jacob Sherkow

Research output: Contribution to journalReview articlepeer-review

Abstract

Given the exciting applications of CRISPR in fields ranging from gene therapy to genetically modified foods, there has naturally been intense scrutiny of the ongoing dispute regarding the discovery and patenting of CRISPR gene editing technology. No one has covered this story more intensively or adeptly than Professor Jacob Sherkow, an academic law professor at New York Law School. In this interview conducted by Dr. Kevin Davies (Executive Editor, The CRISPR Journal), Professor Sherkow provides a brief accessible history of the ongoing CRISPR patent dispute, discussing the implications as well as other legal issues, impacting the world of biotechnology. (This is a lightly edited version of the conversation, which was held on March 20, 2018.).

Original languageEnglish (US)
Pages (from-to)126-130
Number of pages5
JournalBiotechnology Law Report
Volume37
Issue number3
DOIs
StatePublished - Jun 2018
Externally publishedYes

ASJC Scopus subject areas

  • Biotechnology
  • Management, Monitoring, Policy and Law

Fingerprint Dive into the research topics of 'The evolving law of CRISPR interview with professor Jacob Sherkow of New York Law School'. Together they form a unique fingerprint.

Cite this